Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Regs Lead EU Notified Body Association To Suspend Code-Of-Conduct Audits

Executive Summary

TEAM-NB needs to redirect resources from notified body oversight toward helping its 22 members fall into line with requirements under the forthcoming Medical Devices Regulation and IVD Regulation. So what does this mean for TEAM-NB non-members and future notified body numbers?

You may also be interested in...



What's Next For Notified Bodies: TEAM-NB President Discusses Challenges Ahead

A Q&A with Guy Buijzen, of TEAM-NB, on where things stand for notified bodies right now as the EU moves to adopt the new regulations for devices and diagnostics. The EU notified body association is redoubling efforts to prepare its members for the coming changes.

21 Notified Bodies Declare Intention To Stay In EU Game

Almost two dozen notified bodies say they will test against the new European Union Medical Devices Regulation, and 11 against the new IVD Regulation. Some certainty at last, but many questions remain.

EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions

It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103964

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel